Biology Reference
In-Depth Information
27. Reyes-Sandoval A, Fitzgerald JC, Grant R, Roy S, Xiang ZQ, et al. (2004)
Human immunodeficiency virus type 1-specific immune responses in primates
upon sequential immunization with adenoviral vaccine carriers of human and
simian serotypes. J Virol 78: 7392-7399.
28. Garnett CT, Greiner JW, Tsang KY, Kudo-Saito C, Grosenbach DW, et al. (2006)
TRICOM vector based cancer vaccines. Curr Pharm Des 12: 351-361.
29. Kudo-Saito C, Hodge JW, Kwak H, Kim-Schulze S, Schlom J, et al. (2006)
4-1BB ligand enhances tumor-specific immunity of poxvirus vaccines. Vaccine
24: 4975-4986.
30. Abaitua F, Rodriguez JR, Garzon A, Rodriguez D, Esteban M (2006) Improving
recombinant MVA immune responses: potentiation of the immune responses
to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12
and IFN-gamma. Virus Res 116: 11-20.
31. Perera LP, Waldmann TA, Mosca JD, Baldwin N, Berzofsky JA, et al. (2007)
Development of smallpox vaccine candidates with integrated interleukin-15
that demonstrate superior immunogenicity, efficacy, and safety in mice. J Virol
81: 8774-8783.
32. Chavan R, Marfatia KA, An IC, Garber DA, Feinberg MB (2006) Expression of
CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L,
from modified vaccinia virus ankara enhances antiviral cellular and humoral
immune responses. J Virol 80: 7676-7687.
33. Symons JA, Tscharke DC, Price N, Smith GL (2002) A study of the vaccinia
virus interferon-gamma receptor and its contribution to virus virulence. J Gen
Virol 83: 1953-1964.
34. Alcami A, Khanna A, Paul NL, Smith GL (1999) Vaccinia virus strains Lister,
USSR and Evans express soluble and cell-surface tumour necrosis factor recep-
tors. J Gen Virol 80 (Pt 4): 949-959.
35. Alcami A, Symons JA, Smith GL (2000) The vaccinia virus soluble alpha/beta
interferon (IFN) receptor binds to the cell surface and protects cells from the
antiviral effects of IFN. J Virol 74: 11230-11239.
36. Alejo A, Ruiz-Arguello MB, Ho Y, Smith VP, Saraiva M, et al. (2006) A
chemokine-binding domain in the tumor necrosis factor receptor from variola
(smallpox) virus. Proc Natl Acad Sci U S A 103: 5995-6000.
37. Kettle S, Alcami A, Khanna A, Ehret R, Jassoy C, et al. (1997) Vaccinia virus
serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects
virus-infected cells from TNF- and Fas-mediated apoptosis, but does not pre-
vent IL-1beta-induced fever. J Gen Virol 78 (Pt 3): 677-685.
Search WWH ::




Custom Search